Yang Lili, Yun Peng, Li Fangping
Department of Endocrinology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
Front Endocrinol (Lausanne). 2025 Jul 24;16:1602844. doi: 10.3389/fendo.2025.1602844. eCollection 2025.
Thyroid cancer (TC) has shown a rising prevalence worldwide. While numerous studies have explored the relationship between vitamin D levels and TC risk, their conclusions remain inconsistent.
This meta-analysis aims to evaluate the association between serum vitamin D levels, vitamin D deficiency, and TC based on existing evidence.
We systematically searched the Embase, Web of Science, and PubMed databases for human studies investigating the relationship between vitamin D and TC including a control group. A random-effects model with forest plots was employed to calculate the mean difference (MD) in serum vitamin D levels, the odds ratio (OR) for vitamin D deficiency, and the risk difference (RD) between TC cases and controls. Meta-regressions and subgroup analyses were conducted based on the season of serum 25(OH)D sampling, source of controls, timing of measurement, study type, and testing methods of 25(OH)D. A -value <0.05 was considered statistically significant.
A total of 23 studies were included. The meta-analysis revealed that TC patients had significantly lower serum vitamin D compared to the controls [SMD = -0.38 (95% CI: -0.62 to -0.14)].Additionally, vitamin D deficiency was significantly more prevalent among TC patients (OR = 1.33, 95% CI: 1.02 to 1.73, < 0.05). The subgroup analyses demonstrated significant differences across most subgroups, except for post-operative measurements. Seasonal variation in 25(OH)D sampling was identified as a key source of heterogeneity.
The meta-analysis suggests that lower serum vitamin D levels and vitamin D deficiency are significantly associated with an increased risk of TC. However, further studies with standardized protocols for seasonal sampling of vitamin D, source of control, measurement timing, study type, and testing methods of 25(OH)D are needed to clarify this relationship and its underlying mechanisms.
甲状腺癌(TC)在全球范围内的患病率呈上升趋势。尽管众多研究探讨了维生素D水平与TC风险之间的关系,但其结论仍不一致。
本荟萃分析旨在根据现有证据评估血清维生素D水平、维生素D缺乏与TC之间的关联。
我们系统检索了Embase、Web of Science和PubMed数据库,以查找研究维生素D与TC关系(包括对照组)的人体研究。采用带有森林图的随机效应模型计算血清维生素D水平的平均差异(MD)、维生素D缺乏的比值比(OR)以及TC病例与对照之间的风险差异(RD)。基于血清25(OH)D采样季节、对照来源、测量时间、研究类型以及25(OH)D检测方法进行Meta回归和亚组分析。P值<0.05被认为具有统计学意义。
共纳入23项研究。荟萃分析显示,与对照组相比,TC患者的血清维生素D显著降低[标准化均数差(SMD)=-0.38(95%置信区间:-0.62至-0.14)]。此外,维生素D缺乏在TC患者中更为普遍(OR=1.33,95%置信区间:1.02至1.73,P<0.05)。亚组分析表明,除术后测量外,大多数亚组之间存在显著差异。25(OH)D采样的季节变化被确定为异质性的关键来源。
荟萃分析表明,较低的血清维生素D水平和维生素D缺乏与TC风险增加显著相关。然而,需要进一步开展具有标准化方案的研究,以明确维生素D的季节采样、对照来源、测量时间、研究类型以及25(OH)D检测方法,从而阐明这种关系及其潜在机制。